Studies

Interventional Recruiting

NCT06639477 on ClinicalTrials.gov

Assessing Improvements in Mood and Sleep Trial

Official title: Multi-site Randomized Controlled Trial Comparing the Efficacy of Behavioral Approaches to Improve Mood and Sleep in Adults

Brief Summary

This is a multi-site randomized control trial involving people age 55+ years who have current depression symptoms plus another suicide risk indicator (either current suicidal ideation or a past history of attempt). Our goal is evaluate which of two different approaches works best to improve things like trouble sleeping, bad moods, and any suicidality.

Participants will complete diagnostic interviews, self-report scales, and wear an actigraphy device for the 8 weeks starting at the baseline visit.

Conditions

  • Depression
  • Suicidality
  • Sleep

Intervention / Treatment

  • Other: Treatment As Usual
  • Behavioral: Active Condition
  • Behavioral: Active Comparator

Primary Outcome Measures

  • Depression Symptom Response (six months post-treatment)
    The outcome is the rate of clinically significant depression symptom responses six-months post treatment, defined as having ≥50% reduction in pre-treatment depression severity six-months posttreatment. Depression severity will be assessed as total scores from the 14 non-sleep items of the clinician rated GRID Hamilton Depression Rating Scale. Lower scores on the GRID Hamilton would indicate a reduction in depression symptoms.

Countries

United States

Locations and Investigators

  • The Regents of the University of California, Los Angeles, Los Angeles, United States (Recruiting)
    • Michael Irwin, PhD
    • Jennifer Kruse, PhD
    • Michael Iriwn, PhD (Principal Investigator)
    • Jennifer Kruse, PhD
  • Augusta University, Augusta, United States (Recruiting)
    • William McCall, PhD
    • Jessica Britt-Thomas, PhD
    • William McCall, PhD (Principal Investigator)
    • Jessica Britt-Thomas, PhD
  • University of Pittsburgh, Pittsburgh, United States (Recruiting)
    • Sara Sellars, M.A
    • Stephen F Smagula, PhD (Principal Investigator)
    • Daniel J Buysse, MD

Study Officials

  • Stephen F Smagula, Ph.D (Principal Investigator) — University of Pittsburgh